Every Form 4 that Stepan Co. (SCL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SCL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SCL filings page.
STEPAN CO (SCL) reported insider equity activity by officer Shawn G. Lisle (VP GC & Secretary). On 2026-08-26, Lisle exercised 1,154 restricted stock units (RSUs), receiving an equal number of common shares per the award terms. To cover tax liability on the RSU vesting, 339 common shares were withheld at $62.345 per share. Following the exercise, Lisle holds 2,308 RSUs, each representing a contingent right to receive one share of Stepan common stock.
Stepan Co senior vice president and chief financial officer Ruben Dario Velasquez reported the vesting and settlement of 1,358 Restricted Stock Units (RSUs) on August 10, 2026. Each RSU represented a contingent right to receive one share of common stock, and the RSUs were settled in common shares at a reference price of $64.675 per share. In connection with the vesting, 398 common shares were withheld to satisfy tax liabilities, with the remainder retained as directly owned common stock. After the derivative transaction, 2,716 RSUs remained outstanding, vesting ratably over three years beginning on the award date.
Stepan Company VP and GM Surfactants-INT Robin Joseph Weitkamp reported routine compensation-related equity activity involving restricted stock units (RSUs) and common stock.
On May 11, 2026, 90 RSUs were settled into 90 shares of common stock per the award terms. To cover tax obligations on the RSU vesting, 50 shares of common stock were withheld at a value of $52.58 per share, leaving 40 shares of common stock held directly after the transactions. The filing also shows 96.9 shares of common stock held indirectly through the ESOP II Trust.
Stepan Company vice president, general counsel and secretary Shawn G. Lisle reported equity compensation awards and a correction to a prior filing. On March 2, 2026, he received 6,440 stock appreciation rights with a conversion price of $50.06, 2,247 performance shares, and 4,495 restricted stock units, each tied to one share of common stock. A separate February 27, 2026 entry shows a grant of 25.544 shares of common stock at $52.51 per share. The amendment updates the previously reported stock appreciation right exercise price from $17.47 to $50.06; all other terms remain unchanged.
Stepan Co VP & CHRO Andrea Jean Barry reported equity-based compensation grants and a correction to a prior filing. On March 2, 2026, she received 6,440 stock appreciation rights with a conversion price of $50.06, 2,247 performance shares, and 4,495 restricted stock units, each tied to one share of common stock. The RSUs vest ratably over three years, while the performance shares vest if Stepan Company certifies that certain performance goals are achieved for the period ending December 31, 2028. She also acquired 16.464 shares of common stock on February 27, 2026 as a grant. This Form 4/A amends the original Form 4 only to correct the stock appreciation right conversion price to $50.06 from $17.47; all other terms of the reported transactions remain unchanged.
STEPAN CO executive Sean Thomas Moriarty, VP & GM Surfactants, reported multiple equity-based compensation awards. On March 2, 2026, he received 4,495 restricted stock units, 2,247 performance shares, and 6,440 stock appreciation rights with a $50.06 exercise price. On February 27, 2026, he also acquired 56.765 shares of common stock as an award. The filing shows 14,205.2335 common shares held directly and 4,478.351 shares held indirectly through an ESOP II trust as of that date. This Form 4/A amends a prior filing solely to correct the stock appreciation right exercise price from $17.47 to $50.06; all other terms remain unchanged.
STEPAN CO executive Richard Finn, V.P. and General Manager of Polymers, reported new equity compensation awards. He received a stock appreciation right covering 7,155 shares of common stock with a conversion price of $50.06 per share, expiring on March 3, 2036. He was also granted 2,497 performance shares and 4,994 restricted stock units, each representing the right to receive one share of common stock, with the performance shares tied to goals for a period ending December 31, 2028. The RSUs and certain awards vest ratably over three years starting on the grant date.
This amended Form 4 corrects the previously reported conversion price of the stock appreciation right from $17.47 to $50.06; all other terms of the transaction remain unchanged. Following these awards, Finn reports 241,395.915 shares of common stock held directly, along with additional indirect holdings through an ESOP trust, a personal trust, and family accounts.
STEPAN CO Vice President and Chief Financial Officer Ruben Dario Velasquez reported multiple equity-based awards and an administrative correction. On March 2, 2026, he received 8,586 Stock Appreciation Rights tied to common stock with a conversion/exercise price of $50.06 and expiration on March 3, 2036. He was also granted 2,996 performance shares, which vest upon certification that performance goals for the period ending December 31, 2028 are achieved, and 5,993 restricted stock units that vest ratably over three years beginning on the grant date. In a separate award dated February 27, 2026, he acquired 35.601 shares of common stock at $52.51 per share. This Form 4/A amends a prior filing solely to correct the Stock Appreciation Right conversion/exercise price to $50.06 from $17.47; no other terms of the reported transactions are changed.
STEPAN CO executive Robert Joseph Haire reported multiple equity awards and corrected prior pricing details. The filing shows grants on March 2, 2026 of 8,586 Stock Appreciation Rights tied to common stock at a conversion/exercise price of $50.06, 2,996 performance shares, and 5,993 restricted stock units.
He also acquired 56.765 shares of common stock at $52.51 per share, bringing direct common stock holdings to 2,538.765 shares, plus 90.269 shares held indirectly through an ESOP II Trust. This Form 4/A amends a prior report only to correct the Stock Appreciation Right exercise price from $17.47 to $50.06; all other aspects of the reported transaction remain unchanged.
STEPAN CO President & CEO Luis Rojo reported several equity compensation awards. On March 2, 2026, he received 57,241 stock appreciation rights with a conversion price of $50.06, 39,952 performance shares, and 19,976 restricted stock units, each tied to one share of common stock. On February 27, 2026, he was granted 56.765 shares of common stock at $52.51. The filing also corrects an earlier Form 4 by revising the SAR conversion price to $50.06 from $17.47 due to an administrative error.
STEPAN CO director F. Painter Corning received a stock award of 2,566 shares of Common Stock on May 8, 2026. The grant is recorded at a price of $52.61 per share and is classified as a grant, award, or other acquisition rather than an open-market purchase. Following this non-derivative equity award, Corning directly holds 4,999 shares of Stepan common stock. This reflects routine director compensation in equity form, not a discretionary market trade.
STEPAN F QUINN JR reported acquisition or exercise transactions in this Form 4 filing.
STEPAN CO director Quinn Stepan Jr. reported a stock award of 2,566 shares of common stock on May 8, 2026, received as a grant rather than an open-market purchase, at a reported price of $52.61 per share. After this award, his directly held common stock position stands at 143,007.262 shares.
The filing also updates a series of indirect holdings in various related entities and family accounts, showing post-transaction balances such as 160,000 shares held by a Family LLC and 87,500 shares held by Family Trust IV, among others. Several other indirect entries, including certain family trusts and plan-related positions, are shown with zero balances, reflecting current reported holdings rather than clear buy or sell activity.
STEPAN CO director Jan Stern Reed received a grant of 2,566 shares of Common Stock on May 8, 2026. The award is recorded at $52.61 per share and is classified as a grant, award, or other acquisition rather than an open-market purchase. Following this equity award, Reed directly holds 16,477 shares of STEPAN CO Common Stock.
Lewis Susan reported acquisition or exercise transactions in this Form 4 filing.
Stepan Co director Susan Lewis received a compensation-related grant of 2,566 shares of Common Stock on May 8, 2026, at a price of $52.61 per share. Following this award, her directly held stake increased to 6,962 shares of Stepan Co common stock.
STEPAN CO director Joaquin Delgado received a grant of 2,566 shares of Common Stock on May 8, 2026. The award is recorded at $52.61 per share, reflecting a compensation-related acquisition rather than an open-market purchase. Following this grant, Delgado directly holds 18,637 shares of Stepan common stock.
Burgess Lorinda reported acquisition or exercise transactions in this Form 4 filing.
STEPAN CO director Lorinda Burgess received a grant of 2,566 shares of Common Stock on May 8, 2026. The award was recorded at a price of $52.61 per share, reflecting compensation rather than an open-market purchase. Following this grant, she directly holds 5,900 Common Stock shares in total.
STEPAN CO director Randall S. Dearth received a grant of 2,566 shares of Common Stock on May 8. The shares were awarded at a reference price of $52.61 per share and are characterized as a grant, award, or other acquisition rather than an open-market purchase. Following this compensation-related award, his direct holdings increased to 16,672 shares of STEPAN CO Common Stock, indicating a routine adjustment to his equity position as a board member.
Stepan Company executive Robert Joseph Haire reported routine equity compensation activity involving restricted stock units (RSUs). On May 1, 2026, 550 RSUs were settled into the same number of common shares, consistent with the award terms that each RSU converts into one share.
To cover associated tax liabilities on the RSU vesting, 162 common shares were withheld, a non‑market disposition that does not represent an open‑market sale. After these transactions, Haire directly holds approximately 3,959.765 shares of Stepan common stock.
Stepan Co vice president Robin Joseph Weitkamp received new equity awards as part of compensation. On April 13, 2026, he was granted 2,859 restricted stock units, each representing a contingent right to one share of Stepan common stock, vesting ratably over three years.
He also received 4,030 stock appreciation rights on Stepan common stock at an exercise price of $52.46 per share, exercisable beginning April 13, 2027 and expiring April 13, 2036. In addition, he was granted 1,429 performance shares, each a contingent right to one share that vests only if Stepan certifies that performance goals are achieved for the period ending December 31, 2028. These awards are grants, not open‑market purchases or sales.
Stepan Company VP and GM Surfactants NA Afonso Adriano Jose Galimberti received new equity-based awards as part of his compensation. On April 13, 2026, he was granted 1,310 performance shares, 2,621 restricted stock units, and 3,694 stock appreciation rights with a $52.46 exercise price. The performance shares vest if Stepan meets performance goals for the period ending December 31, 2028. The restricted stock units vest ratably over three years beginning on the grant date.
Stepan Company executive Richard Finn reported mixed equity transactions tied to restricted stock units (RSUs). On March 3 and 4, 2026, RSUs covering 1,253 and 429 units were settled into an equal number of Stepan common shares per award terms.
To cover tax liabilities on these vestings, Finn disposed of 434 and 149 common shares through tax-withholding transactions at prices of $48.985 and $49.615 per share. He continues to hold additional shares both directly and indirectly through family members and various trusts, as reflected in updated ownership balances.
Stepan Company President & CEO Luis Rojo reported equity award activity involving restricted stock units (RSUs) and common stock on March 3–4, 2026. RSUs were converted into common shares, and a portion of those shares was withheld to cover tax obligations.
On March 3, Rojo exercised 4,455 RSUs into the same number of Stepan common shares at a reference price of $48.985, then delivered 1,306 shares to satisfy tax liability. On March 4, he exercised another 857 RSUs at $49.615, with 252 shares withheld for taxes.
After these transactions, Rojo directly owned 19,451.666 shares of Stepan common stock and held 858 RSUs, with an additional 511.83 shares held indirectly through the ESOP II Trust.
Stepan Company executive Robert Joseph Haire reported equity award activity involving restricted stock units and common stock. On March 3 and 4, 2026, RSUs covering 2,241 shares were converted into Stepan common stock, consistent with the award terms that settle each RSU in one share.
To cover associated tax liabilities on these RSU vestings, Haire disposed of 658 common shares through share withholding transactions coded “F,” rather than open-market sales. After these transactions, he held 4,121.765 common shares directly and an additional 90.269 shares indirectly through the ESOP II Trust.
Stepan Company executive Sean Thomas Moriarty reported RSU vesting transactions and related tax withholding. On March 3 and 4, 2026, restricted stock units converted into common shares per award terms, and a portion of the resulting stock was withheld to cover tax liabilities, with remaining shares increasing his direct ownership.
Stepan Company executive Sean Thomas Moriarty reported multiple equity awards and updated holdings. On March 2, 2026, he was granted 6,440 Stock Appreciation Rights, 2,247 performance shares, and 4,495 restricted stock units, each generally vesting ratably over three years beginning on that grant date.
The performance shares vest upon certification that Stepan Company meets performance goals for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.51 per share as an award, bringing his direct common stock holdings to 14,205.2335 shares and his indirect holdings via the ESOP II Trust to 4,478.351 shares. A prior Form 4 incorrectly stated the Stock Appreciation Right amount and is corrected in this amendment.
Stepan Co vice president, general counsel and secretary Shawn G. Lisle reported multiple equity awards. On March 2, 2026, he received 4,495 restricted stock units, 2,247 performance shares and 6,440 stock appreciation rights, all as grants with no cash paid. On February 27, 2026, he also acquired 25.544 shares of common stock at $52.51 per share as an award. The RSUs vest in equal portions over three years, while the performance shares vest if Stepan meets specified performance goals for a period ending on December 31, 2028.
Stepan Company executive Andrea Jean Barry, VP & CHRO, reported multiple stock-based awards. On March 2, 2026, she acquired 4,495 restricted stock units, 2,247 performance shares, and 6,440 stock appreciation rights, all at a stated price of $0.00 per unit.
The RSUs vest ratably over three years starting on the grant date. The performance shares each represent one share of common stock and vest only if Stepan meets specified performance goals for a performance period ending on December 31, 2028. On February 27, 2026, she was also granted 16.464 shares of common stock at $52.51 per share.
Stepan Company executive Robert Joseph Haire, EVP, Supply Chain, reported multiple equity awards. On March 2, 2026, he acquired 5,993 Restricted Stock Units, 2,996 Performance Shares, and 8,586 Stock Appreciation Rights as grant or award acquisitions, all at a stated price of $0.0000 per unit.
Each RSU represents a contingent right to receive one share of Stepan common stock and vests ratably over three years beginning on the grant date. The performance shares vest upon certification that Stepan achieves specified performance goals for the performance period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock as a grant or award, and an indirect holding of 90.269 common shares is shown as held by ESOP II Trust.
Stepan Company executive Sean Thomas Moriarty, VP & GM Surfactants, reported multiple equity awards. On March 2, 2026, he was granted 7,155 Stock Appreciation Rights that vest ratably over three years, 4,495 Restricted Stock Units, and 2,247 performance shares, each representing a contingent right to one share of Stepan common stock.
The performance shares vest upon certification that Stepan achieved specified performance goals for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.5100 per share. The filing notes an additional 4,478.3510 common shares held indirectly through an ESOP II Trust.
STEPAN CO reported that executive Richard Finn Stepan, Vice President and General Manager, Polymers, received several equity incentives. On March 2, 2026, he was granted 7,155 stock appreciation rights that vest ratably over three years, beginning on that date.
He also acquired 2,497 performance shares and 4,994 restricted stock units, each representing a contingent right to receive one share of Stepan common stock. The performance shares vest when the company certifies that performance goals for the period ending December 31, 2028 are achieved, while the RSUs vest ratably over three years from the grant date.
On February 27, 2026, he was awarded 56.765 shares of common stock at $52.51 per share. The filing also lists indirect common stock holdings attributed to his daughter, son, spouse, a trust, and an ESOP II trust, reflecting additional ownership positions reported as indirect.
STEPAN CO reported new equity awards granted to Vice President and Chief Financial Officer Ruben Dario Velasquez. On February 27, 2026, he acquired 35.601 shares of common stock at $52.51 per share as an award. On March 2, 2026, he received grants of 5,993 restricted stock units, 2,996 performance shares, and 8,586 stock appreciation rights, all recorded at a price of $0. Each restricted stock unit and performance share represents a contingent right to receive one share of common stock, with the restricted stock units vesting ratably over three years and the performance shares vesting based on performance goals for a period ending December 31, 2028.
Stepan Co President & CEO Luis Rojo reported equity awards that increase his stake in the company. On March 2, 2026, he received 19,976 Restricted Stock Units, 39,952 performance shares, and a Stock Appreciation Right covering 57,241 shares, all at a stated price of $0.00 per unit.
Each RSU and performance share represents a contingent right to receive one share of Stepan common stock, with RSUs vesting in equal installments over three years and performance shares vesting after certification of performance for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.51 per share, bringing his directly held common stock to 15,697.666 shares, plus 511.83 shares held indirectly through an ESOP II trust.
STEPAN CO President & CEO Luis Rojo reported equity award activity involving restricted stock units and common shares. On the reported date, 683 restricted stock units were exercised and settled into 683 shares of common stock at $66.3900 per share. To cover tax obligations, 237 common shares were disposed of through a tax-withholding transaction, leaving 15,640.901 common shares held directly after these transactions. An additional 511.8300 common shares are held indirectly through the Esop II Trust. The filing also amends a prior report to correct the dates for “Date Exercisable” and “Expiration Date” on the related award.
STEPAN CO executive Richard Finn, Vice President and General Manager of Polymers, reported equity award activity in company stock. On February 17, 2026, 341 restricted stock units were exercised and settled into 341 shares of common stock at $66.39 per share, consistent with the award terms.
To cover taxes on the RSU vesting, 118 shares of common stock were withheld, also at $66.39 per share. After these transactions, Finn directly held 241,339.15 shares of common stock. He also reported indirect holdings, including 43,439 shares held by a daughter, 5,174 by a spouse, 95,416 by a trust, and 1,238.22 by an ESOP II trust.
Stepan Company executive Sean Thomas Moriarty reported equity award activity involving restricted stock units and common stock. On February 17, 2026, 455 restricted stock units were exercised into 455 shares of Stepan common stock at a stated price of $66.39 per share, consistent with an exercise or conversion of derivative securities. To cover tax obligations on the RSU vesting, 158 common shares were disposed of through share withholding, rather than an open-market sale. After these transactions, Moriarty directly holds 14,145.4635 shares of Stepan common stock and indirectly holds 4,478.3510 shares through the ESOP II Trust.
Stepan Company’s President and CEO Luis Rojo reported equity award activity involving restricted stock units and common shares. On February 17, 2026, 683 restricted stock units were settled into 683 shares of common stock, consistent with the award terms where each unit equals one share.
To cover tax obligations related to this settlement, 237 restricted stock units were disposed of at a price of $66.39 per share. Following these transactions, Rojo directly owns 795 restricted stock units and 15,877.901 shares of common stock, plus an additional 511.83 shares held indirectly through the ESOP II Trust.
STEPAN CO director Quinn Stepan Jr. reported an indirect transaction involving share units tied to a deferred compensation arrangement rather than open-market trading. On February 9, 2026, 7,517.35 Share Units, each economically equivalent to one share of common stock, were involved in an exercise or conversion of a derivative security under the Management Incentive Plan, a nonqualified deferred compensation plan. According to the footnotes, these share units were settled in cash, and the holdings are reported as indirect, including amounts held through a father's deferred MIP and an estate for which he serves as executor. After the transaction, indirect holdings related to this arrangement totaled 35,649.518 Share Units.
Stepan Company director F. Quinn Stepan Jr. reported exercising 34,741 employee stock options on January 13, 2026 at an exercise price of $43.85 per share. The options converted into the same number of Stepan common shares in an exercise-and-hold transaction, leaving him with 160,960.262 common shares held directly.
In addition to these directly held shares, the filing lists various indirect holdings of Stepan common stock through entities such as a family LLC, several family trusts, an ESOP trust, and accounts associated with his spouse and other family members. For certain of these positions, he disclaims beneficial ownership except to the extent of any pecuniary interest, and some shares are held in estates or plans where he serves in an administrative role.
Stepan Company insider Luis Rojo, who serves as President & CEO and a director of Stepan Company, reported routine equity compensation activity. On 12/31/2025, restricted stock units (RSUs) covering 4,202 shares were settled in Stepan common stock at a price of $47.205 per share, consistent with the award terms. Each RSU represents a right to receive one share of Stepan common stock.
To cover tax obligations arising from the RSU vesting, 1,232 RSUs were withheld at a price of $47.205 per share. Following these transactions, Rojo beneficially owned 15,194.901 shares of Stepan common stock directly, 511.83 shares indirectly through the Esop II Trust, and continued to hold 7,175 RSUs and other derivative equity interests.
Stepan Company executive Robert Haire reported equity award activity involving Stepan Co. (SCL) common stock. On 12/31/2025, restricted stock units (RSUs) were settled in shares of common stock, resulting in the acquisition of 1,891 shares at a price of $47.205 per share. After this transaction, Haire beneficially owned 2,482 shares of common stock directly and 90.269 shares indirectly through an ESOP II Trust.
In connection with the RSU vesting, 574 RSUs were withheld to satisfy tax liabilities, leaving 1,318 RSUs beneficially owned following the reported transactions. Each RSU represents a contingent right to receive one share of Stepan Company common stock, and these RSUs vest ratably over two years beginning on the date shown.
Stepan Co director reports an insider stock transaction. A director of Stepan Co (ticker SCL) filed a Form 4 for a transaction dated 12/23/2025. The filing shows a gift transaction (code G) of 95.858 shares of Stepan common stock at a stated price of $0, reflecting a transfer without consideration. After this transaction, the director directly beneficially owns 126,219.262 shares of Stepan common stock.
The report also lists extensive indirect holdings in Stepan common stock through various vehicles, including an ESOP II trust, multiple family limited liability companies and family trusts, a spouse, a father, and an estate, with certain interests expressly disclaimed except to the extent of any pecuniary interest.
Stepan Company executive Richard F. Stepan, V.P. and General Manager of Polymers, reported an insider transaction involving the company’s common stock. On 12/23/2025, he reported a transaction coded "G," indicating a gift of shares at a price of $0 per share. After this transaction, he directly beneficially owned 241,116.15 shares of Stepan common stock.
In addition to his direct holdings, the filing lists indirect ownership through family members and trusts, including shares held by a daughter, a son, a spouse, a trust, and an ESOP II trust. This Form 4 reflects a change in how some shares are held and reported, rather than a market sale or purchase for cash.
Stepan Company (SCL) — Officer equity grants reported. On 11/07/2025, the VP & CHRO reported awards of 1,159 Restricted Stock Units, 1,638 Stock Appreciation Rights with an exercise price of $43.15, and 579 performance shares.
The RSUs and SARs vest ratably over three years beginning 11/07/2026; the RSUs expire 11/07/2028 and the SARs expire 11/07/2035. The performance shares vest upon certification of performance goals for the period ending December 31, 2027.